|
|
|
Volumn 4 Suppl 2, Issue , 2003, Pages
|
|
Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCIUM CHANNEL L TYPE;
HYDRAZONE DERIVATIVE;
PYRIDAZINE DERIVATIVE;
SIMENDAN;
VASODILATOR AGENT;
CONGESTIVE HEART FAILURE;
DRUG EFFECT;
EUROPEAN UNION;
HEART CONTRACTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
MORBIDITY;
PATHOPHYSIOLOGY;
REVIEW;
TREATMENT OUTCOME;
UNITED STATES;
CALCIUM CHANNELS, L-TYPE;
EUROPEAN UNION;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYDRAZONES;
MORBIDITY;
MYOCARDIAL CONTRACTION;
MYOCARDIAL ISCHEMIA;
PYRIDAZINES;
TREATMENT OUTCOME;
UNITED STATES;
VASODILATOR AGENTS;
|
|
EID: 2142835896
PISSN: 1129471X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (9)
|
|
References (33)
|
